환자 모니터링 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Patient Monitoring Devices Market Summary

The global patient monitoring devices market size was valued at USD 50.36 billion in 2024 and is expected to reach USD 118.21 billion by 2033, growing at a CAGR of 10.21% from 2025 to 2033. The expansion of the industry can be attributed to the increasing demand for monitoring devices that measure, record, and display various biometric data, including blood pressure, temperature, and blood oxygen saturation levels.

The growing geriatric population, rising prevalence of chronic conditions such as cardiovascular diseases, diabetes, and respiratory disorders, and the increasing need for continuous monitoring are key drivers supporting market growth. For instance, the World Health Organization estimates that by 2030, one in six people globally will be 60 years or older, amplifying the demand for technologies that enable timely intervention and remote care. Rising adoption of telehealth and remote patient monitoring programs is driven by healthcare cost pressures and staffing shortages. For instance, the AMA Digital Health Care 2022 study highlighted that 93% of physicians find digital tools beneficial, with remote patient monitoring (RPM) usage more than doubling to 30% since 2016. This growing adoption reflects strong clinician confidence in connected monitoring devices for managing chronic diseases, post-acute recovery, and preventive care.

Technological developments in miniaturization, battery life, and wireless connectivity are further driving the market. For instance, in The FDA has cleared Dexcom's G7 15-Day Continuous Glucose Monitoring (CGM) system for adults with diabetes. This next-generation device offers up to 15.5 days of wear time, improved accuracy with an 8.0% MARD, and a 12-hour grace period, making it the longest-lasting and most precise CGM currently available in the U.S. market. Similarly, in September 2022, Medtronic announced the FDA clearance of its LINQ II insertable cardiac monitor with Bluetooth connectivity, offering real-time arrhythmia data transmission to physicians and facilitating earlier intervention. These innovations highlight how continuous improvements in device design and connectivity are enhancing remote monitoring capabilities and supporting proactive chronic disease management.

Global Patient Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global patient monitoring devices market report based on product, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Blood Glucose Monitoring Systems
  • Self-monitoring Blood Glucose Systems
  • Continuous Glucose Monitoring Systems
• Cardiac Monitoring Devices
  • ECG Devices
  • Implantable Loop Recorders
  • Event Monitors
  • Mobile Cardiac Telemetry Monitors
  • Smart/Wearable ECG Monitors
• Multi-parameter Monitoring Devices.
  • Low-acuity Monitoring Devices
  • Mid-acuity Monitoring Devices
  • High-acuity Monitoring Devices
• Respiratory Monitoring Devices
  • Pulse Oximeters
  • Spirometers
  • Capnographs
  • Peak Flow Meters
• Temperature Monitoring Devices
  • Handheld Temperature Monitoring Devices
  • Table-top Temperature Monitoring Devices
  • Wearable Continuous Monitoring Devices
  • Invasive Temperature Monitoring Devices
  • Smart Temperature Monitoring Devices
• Hemodynamic/Pressure Monitoring Devices
  • Hemodynamic Monitors
  • Blood Pressure Monitors
  • Disposables
• Fetal & Neonatal Monitoring Devices
  • Fetal Monitoring Devices
  • Neonatal Monitoring Devices
• Neuromonitoring Devices
  • Electroencephalograph Machines
  • Electromyography Machines
  • Cerebral Oximeters
  • Intracranial Pressure Monitors
  • Magnetoencephalograph Machines
  • Transcranial Doppler Machines
• Wearable Drug Delivery Systems
• Weight Monitoring Devices
  • Digital
  • Analog
• Other Patient Monitoring Devices
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers
• Home Care Settings
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. End use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Patient Monitoring Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Product Pipeline Analysis, by Stage
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
  • 3.4.2. Market restraint analysis
  • 3.4.3. Industry challenges Analysis
  • 3.4.4. Industry Opportunity Analysis
• 3.5. Patient Monitoring Devices: Market Analysis Tools
  • 3.5.1. Industry analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat from new entrants
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Environmental landscape
    • 3.5.2.3. Social landscape
    • 3.5.2.4. Technology landscape
    • 3.5.2.5. Legal landscape
• 3.6. Major deals & strategic alliances analysis
• 3.7. Case Studies
• 3.8. Technological Advancement

Chapter 4. Patient Monitoring Devices Market: Segment Analysis, by Product, 2021 - 2033 (USD Million)

• 4.1. Segment Dashboard
• 4.2. Product Market Share Analysis, 2021 & 2033
• 4.3. Global Patient Monitoring Devices Market, by Product, 2021 to 2033
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
  • 4.4.1. Blood Glucose Monitoring Systems
    • 4.4.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.2. Self-monitoring blood glucose systems
      • 4.4.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.3. Continuous Glucose Monitoring System
      • 4.4.1.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Cardiac Monitoring Devices
    • 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.2. ECG Devices
      • 4.4.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.3. Implantable Loop Records
      • 4.4.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.4. Event Monitors
      • 4.4.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.5. Mobile Cardiac Telemetry Monitors
      • 4.4.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.6. Smart/Wearable ECG Monitors
      • 4.4.2.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Multi-parameter Monitoring Devices.
    • 4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.2. Low-acuity Monitoring Devices
      • 4.4.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.3. Mid-acuity Monitoring Devices
      • 4.4.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.4. High-acuity Monitoring Devices
      • 4.4.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Respiratory Monitoring Devices
    • 4.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.2. Pulse Oximeters
      • 4.4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.3. Spirometer
      • 4.4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.4. Capnographs
      • 4.4.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.5. Peak Flow Meters
      • 4.4.4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Temperature Monitoring Devices
    • 4.4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5.2. Handheld Temperature Monitoring Devices
      • 4.4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5.3. Table-top Temperature Monitoring Devices
      • 4.4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5.4. Wearable Continuous Monitoring Devices
      • 4.4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5.5. Invasive Temperature Monitoring Devices
      • 4.4.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.6. Smart Temperature Monitoring Devices
    • 4.4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.7. Hemodynamic/ Pressure Monitoring Devices
    • 4.4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.7.2. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.7.3. Hemodynamic Monitoring Devices
      • 4.4.7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.7.4. Blood Pressure Monitors
      • 4.4.7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.7.5. Disposable
      • 4.4.7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.8. Fetal & Neonatal Monitoring Devices
    • 4.4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.8.2. Fetal Monitoring Devices
      • 4.4.8.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.8.3. Neonatal Monitoring Devices
      • 4.4.8.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.9. Neuromonitoring Devices
    • 4.4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.9.2. Electroencephalograph Machines
      • 4.4.9.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.9.3. Electromyography Machines
      • 4.4.9.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.9.4. Cerebral Oximeters
      • 4.4.9.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.9.5. Intracranial Pressure Monitors
      • 4.4.9.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.9.6. Magnetoencephalograph Machines
      • 4.4.9.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.9.7. Transcranial Doppler Machines
      • 4.4.9.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.10. Weight Monitoring Devices
    • 4.4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.10.2. Digital
      • 4.4.10.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.10.3. Analog
      • 4.4.10.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.11. Wearable Drug Delivery Systems
    • 4.4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.12. Other Patient Monitoring Devices
    • 4.4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Patient Monitoring Devices Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. End use Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Patient Monitoring Devices Market, by End Use, 2021 to 2033
• 5.5. Hospitals
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Ambulatory Surgery Centers
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Home Care Settings
  • 5.7.1. Home Care Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Patient Monitoring Devices Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 6.1. Regional Market Share Analysis, 2024 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. Patient Monitoring Devices Market Share by Region, 2024 & 2033:
• 6.5. North America
  • 6.5.1. North America Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Scenario
    • 6.5.2.3. Competitive Scenario
    • 6.5.2.4. U.S. Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Scenario
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. Canada Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Scenario
    • 6.5.4.3. Competitive Scenario
    • 6.5.4.4. Mexico Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Scenario
    • 6.6.2.3. Competitive Scenario
    • 6.6.2.4. UK Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Scenario
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. Germany Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Scenario
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. France Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Scenario
    • 6.6.5.3. Competitive Scenario
    • 6.6.5.4. Italy Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Scenario
    • 6.6.6.3. Competitive Scenario
    • 6.6.6.4. Spain Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.7. Norway
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Scenario
    • 6.6.7.3. Competitive Scenario
    • 6.6.7.4. Norway Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Regulatory Scenario
    • 6.6.8.3. Competitive Scenario
    • 6.6.8.4. Sweden Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.9. Denmark
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Regulatory Scenario
    • 6.6.9.3. Competitive Scenario
    • 6.6.9.4. Denmark Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Regulatory Scenario
    • 6.7.1.3. Competitive Scenario
    • 6.7.1.4. Japan Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Scenario
    • 6.7.2.3. Competitive Scenario
    • 6.7.2.4. China Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Scenario
    • 6.7.3.3. Competitive Scenario
    • 6.7.3.4. India Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Regulatory Scenario
    • 6.7.4.3. Competitive Scenario
    • 6.7.4.4. Australia Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Regulatory Scenario
    • 6.7.5.3. Competitive Scenario
    • 6.7.5.4. South Korea Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Regulatory Scenario
    • 6.7.6.3. Competitive Scenario
    • 6.7.6.4. Thailand Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key Country Dynamics
    • 6.8.1.2. Regulatory Scenario
    • 6.8.1.3. Competitive Scenario
    • 6.8.1.4. Brazil Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Scenario
    • 6.8.2.3. Competitive Scenario
    • 6.8.2.4. Argentina Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key Country Dynamics
    • 6.9.1.2. Regulatory Scenario
    • 6.9.1.3. Competitive Scenario
    • 6.9.1.4. South Africa Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Regulatory Scenario
    • 6.9.2.3. Competitive Scenario
    • 6.9.2.4. Saudi Arabia Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Regulatory Scenario
    • 6.9.3.3. Competitive Scenario
    • 6.9.3.4. UAE Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Regulatory Scenario
    • 6.9.4.3. Competitive Scenario
    • 6.9.4.4. Kuwait Patient Monitoring Devices Market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Market Share Analysis, 2024 (%)
• 7.4. Company Profiles
  • 7.4.1. Bosch
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Biotronik
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Welch Allyn
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Koninklijke Philips N.V.
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. GE Healthcare
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Medtronic
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. MASIMO CORPORATION
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Smiths Medical
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. OMRON Corporation
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Mindray Medical India Pvt. Ltd.
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. F. Hoffmann-La Roche Ltd
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Dragerwerk AG & Co. KGaA
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. NIHON KOHDEN CORPORATION
    • 7.4.13.1. Company overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives
  • 7.4.14. Natus Medical
    • 7.4.14.1. Company overview
    • 7.4.14.2. Financial performance
    • 7.4.14.3. Product benchmarking
    • 7.4.14.4. Strategic initiatives